1,25-Dihydroxyvitamin D3 increases type 1 interleukin-1 receptor expression in a murine T cell line
- PMID: 8366134
- DOI: 10.1002/jcb.240520208
1,25-Dihydroxyvitamin D3 increases type 1 interleukin-1 receptor expression in a murine T cell line
Abstract
The biologically active metabolite of vitamin D3, 1,25 (OH)2 D3, exerts important immunoregulatory effects in addition to being a central mediator of calcium/phosphate metabolism. Utilizing an interleukin 1 responsive murine T cell line and 125I-interleukin 1 alpha, we show that 1,25 (OH)2 D3 (5,50 nM) enhanced 125I-interleukin 1 alpha binding up to almost 2-fold over control. This 1,25 (OH)2 D3 effect occurred in a dose-dependent manner and was detectable after 24 h but not before 7 h of culture. Scatchard analysis of 125I-interleukin 1 alpha binding data demonstrated that 1,25 (OH)2 D3 enhanced interleukin 1 receptor number without a significant change in affinity. The biologically less potent metabolite of vitamin D3, 25 (OH) D3, also augmented 125I-interleukin 1 alpha binding but at steroid levels 2-3 log orders greater than 1,25 (OH)2 D3. This observation, combined with the presence of high-affinity 3H-1,25 (OH)2 D3 receptors (88 sites/cell, K = 0.45 nM) in cytosolic extracts, strongly suggests that the nuclear vitamin D receptor mediates this steroid's effect on interleukin 1 receptor expression. Based on the capacity of an anti-type 1 interleukin 1 receptor monoclonal antibody (35F5) to block 1,25 (OH)2 D3-enhanced 125I-interleukin 1 alpha binding, we conclude that this steroid augments type 1 interleukin 1 receptor expression. When combined with interleukin 1, a cytokine that also impacts MD10 interleukin 1 receptor expression, 1,25 (OH)2 D3 enhanced interleukin 1 receptor expression. Northern blots hybridized with a 32P-type 1 interleukin 1 receptor cDNA probe show that 1,25 (OH)2 D3 enhanced type 1 interleukin 1 receptor steady state mRNA levels. Functionally, 1,25 (OH)2 D3 pretreatment augmented the MD10 proliferative response to suboptimal levels of interleukin 1 (< 100 fM interleukin 1 alpha). These findings further support 1,25 (OH)2 D3's role as an immunoregulatory molecule and provides a possible mechanism by which this steroid could potentiate certain immune activities.
Similar articles
-
Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3.J Cell Biochem. 1993 Oct;53(2):122-34. doi: 10.1002/jcb.240530205. J Cell Biochem. 1993. PMID: 8227185
-
IL-1 and IL-4 modulate IL-1 receptor expression in a murine T cell line.J Immunol. 1990 Dec 15;145(12):4145-53. J Immunol. 1990. PMID: 2147936
-
Vitamin D affects proliferation of a murine T helper cell clone.J Immunol. 1987 Mar 15;138(6):1680-6. J Immunol. 1987. PMID: 3029220
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
The vitamin D hormone and its nuclear receptor: molecular actions and disease states.J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review.
Cited by
-
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence.Cancer Immunol Immunother. 1995 Jul;41(1):37-45. doi: 10.1007/BF01788958. Cancer Immunol Immunother. 1995. PMID: 7641218 Free PMC article.
-
Vitamin D in inflammatory diseases.Front Physiol. 2014 Jul 2;5:244. doi: 10.3389/fphys.2014.00244. eCollection 2014. Front Physiol. 2014. PMID: 25071589 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources